Potential mild effects observed in animal and in vitro models include transient fatigue, mild nausea, or digestive discomfort related to metabolic acceleration
The medications large molecular size makes it unlikely to pass into milk in significant amounts, and even if it did, it would probably be destroyed in the infants digestive tract
Case reports or observational data on concurrent use have not been published in peer-reviewed literature
In 2026, the class of glucagon-like peptide-1 receptor agonists is no longer defined solely by Ozempic and Wegovy
Stress, boredom, fatigue, and emotional distress commonly trigger desires for comfort foods, including sweets
If needed, the maintenance dose can be increased to 7.2mg